Cellectar Biosciences
CLRB
CLRB
32 hedge funds and large institutions have $1.63M invested in Cellectar Biosciences in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.04% less ownership
Funds ownership: 0.41% → 0.38% (-0.04%)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Holders
32
Holding in Top 10
–
Calls
$18K
Puts
$6K
Top Buyers
| 1 | +$171K | |
| 2 | +$108K | |
| 3 | +$59.5K | |
| 4 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$43.1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$41.3K |
Top Sellers
| 1 | -$172K | |
| 2 | -$64.3K | |
| 3 | -$62.5K | |
| 4 |
Morgan Stanley
New York
|
-$51.5K |
| 5 |
JPMorgan Chase & Co
New York
|
-$48.6K |
